Potential Cost Implications for All US Food and Drug Administration Oncology Drug Approvals in 2018

Patrick C. Demartino, Miloš D. Miljković, Vinay Prasad

Research output: Contribution to journalReview articlepeer-review

28 Scopus citations

Fingerprint

Dive into the research topics of 'Potential Cost Implications for All US Food and Drug Administration Oncology Drug Approvals in 2018'. Together they form a unique fingerprint.

Medicine & Life Sciences